CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Unite de Fabrication de Medicaments SA is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Unite de Fabrication de Medicaments SA
Zone Industrielle De Kalaa Kebira
Phone: +216 73342669p:+216 73342669 SOUSSE, 4060  Tunisia Ticker: UMEDUMED
Business Summary
Unite de Fabrication de Medicaments SA is a Tunisia-based company principally engaged in the pharmaceutical sector. The Company has labaroatories where it develops production in two main areas: Generic Drugs, where it concentrates on the production and marketing of drugs under its own brand of Unimed, and Shaped Drugs, which are the drugs manufactured for third party laboratories customers. The Company's product portfolio comprises Ophthalmology Otorhinolaryngologicals (OPHTA ORL) like Alzor, Atropine Unimed and Benzosept, among others; liquid injections, such as Bupicaine, Furoxem, Doperan and Ketomed, among others; powders for injections, such as Amoxil, Ampicil and Cefaxone, among others; Otorhinolaryngologicals (ORL) like Ofloxacine; and infusion solutions, such as Glucose 5% and Osmomed 5%, among others.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202312/31/2022Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Technical Officer AmelChouaib
Research and Development Pharmacist JasserBedoui
Medical Director MohamedBen Ammar
Director of Logistics LotfiCharfeddine
Director of Marketing LotfiAzouz

General Information
Number of Employees: 760 (As of 9/30/2023)
Outstanding Shares: 32,000,000 (As of 6/30/2023)
Stock Exchange: TUN
Fax Number: +216 73342472


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 25, 2024